1. Home
  2. NOV vs BLCO Comparison

NOV vs BLCO Comparison

Compare NOV & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOV Inc.

NOV

NOV Inc.

HOLD

Current Price

$18.40

Market Cap

6.6B

Sector

Industrials

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.25

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOV
BLCO
Founded
1862
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Metal Fabrications
Ophthalmic Goods
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
6.0B
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
NOV
BLCO
Price
$18.40
$16.25
Analyst Decision
Hold
Buy
Analyst Count
13
12
Target Price
$18.00
$18.55
AVG Volume (30 Days)
4.0M
417.3K
Earning Date
04-27-2026
04-29-2026
Dividend Yield
1.97%
N/A
EPS Growth
N/A
N/A
EPS
0.39
N/A
Revenue
$8,744,000,000.00
$5,101,000,000.00
Revenue This Year
N/A
$8.61
Revenue Next Year
$3.04
$5.52
P/E Ratio
$46.81
N/A
Revenue Growth
N/A
6.47
52 Week Low
$10.84
$10.45
52 Week High
$20.77
$18.92

Technical Indicators

Market Signals
Indicator
NOV
BLCO
Relative Strength Index (RSI) 43.68 37.30
Support Level $17.70 $14.39
Resistance Level $19.22 $17.44
Average True Range (ATR) 0.62 0.53
MACD -0.18 -0.20
Stochastic Oscillator 19.15 13.09

Price Performance

Historical Comparison
NOV
BLCO

About NOV NOV Inc.

NOV designs, manufactures, and sells a wide range of equipment and components supplying the oil and gas industry, including rig equipment, downhole tools, drill pipe, and well casing. NOV's customers include major integrated oil companies, national oil companies, independent oil and gas companies, and drilling contractors. Its operations are organized into two reportable segments: energy products and services and energy equipment. NOV operates on a global scale, with international markets contributing nearly two-thirds of its annual revenue.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: